Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma

HPB : the Official Journal of the International Hepato Pancreato Biliary Association
Shigeki NakagawaHideo Baba

Abstract

Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and regulates tumor malignancy by gene silencing via histone methylation. In this study we investigate the role of EZH2 in angiogenesis of intrahepatic cholangiocarcinoma (ICC). The influence of EZH2 on tumor angiogenesis was examined by bioinformatics analysis of a public database. We also assessed the correlation between EZH2 and vasohibin 1 (VASH1) expression in 47 patients with ICC by immunohistochemical (IHC) staining and in vitro gene silencing assays. The prognostic significance of EZH2 and VASH1 expression by IHC was also examined in the ICC cohort. Bioinformatics analysis showed that EZH2 was associated with several angiogenesis gene sets in the public database. EZH2 suppressed VASH1 expression in in vitro assays and IHC studies. EZH2-high/VASH1-low status was independently associated with poor disease-free survival (P = 0.019) and poor overall survival (P = 0.0055). The current study demonstrated that high EZH2 expression was associated with activation of tumor angiogenesis, and activation of the EZH2-mediated angiogenesis pathway predicted the prognosis of patients with ICC.

References

Jan 1, 1997·Gastroenterology·S K RobertsN F Larusso
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gianfranco AlpiniNicholas F Larusso
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Feb 14, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jikui ShenPeter A Campochiaro
Feb 21, 2006·Biochemical and Biophysical Research Communications·Hikaru SonodaYasufumi Sato
Dec 14, 2006·Critical Reviews in Oncology/hematology·Melanie B Thomas
Aug 17, 2010·Cancer Cell·Chunhua LuAnil K Sood
Nov 3, 2010·Annals of Surgical Oncology·Hirohisa OkabeHideo Baba
Dec 24, 2010·Cancer Science·Kousuke YoshinagaYasufumi Sato
Mar 15, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lakshmi P KunjuCelina G Kleer
Feb 10, 2012·Journal of Hepato-biliary-pancreatic Sciences·Jason E Faris, Andrew X Zhu
Jun 20, 2012·Cancer Metastasis Reviews·Francesco CreaRomano Danesi
Jul 5, 2012·The Keio Journal of Medicine·Yoshiaki Kubota
Sep 13, 2012·Proceedings of the National Academy of Sciences of the United States of America·Renhai CaoYihai Cao
Nov 13, 2012·Acta Neuropathologica·Karl H PlateDaniel J Dumont
Dec 12, 2012·Journal of Internal Medicine·L Claesson-Welsh, M Welsh
Mar 19, 2013·Experimental Cell Research·Lauri Eklund, Pipsa Saharinen
May 1, 2013·International Journal of Molecular Sciences·Markus WehlandDaniela Grimm
Dec 25, 2013·Medical Oncology·Yichao YanShan Wang
Sep 6, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tijana MitićCostanza Emanueli
Jan 16, 2016·Cell Systems·Arthur LiberzonPablo Tamayo
Feb 24, 2016·Cancer Chemotherapy and Pharmacology·Ya-Tian ChenLing-Hui Zeng

❮ Previous
Next ❯

Citations

Jun 2, 2020·Cell Biochemistry and Function·Shuangling LiChangqing Xu
Jun 9, 2020·Clinical Genetics·Roya RamezankhaniCatherine M Verfaillie
Nov 12, 2020·Pharmacology & Therapeutics·Roya RamezankhaniMoustapha Hassan
Apr 24, 2021·Expert Review of Gastroenterology & Hepatology·Antonio CiglianoDiego F Calvisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.